St. Jude Biocor Would Capitalize On Broad Stented Tissue Valve Market
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical plans to launch four new tissue mitral valves in the U.S. in the third quarter of 2005, including the Biocor stented porcine valve